NSE · Healthcare · Medical Instruments & Supplies
EPS came in at 1.42 against a street estimate of 1.10 — a beat of 29.1%.
with an average price target of ₹584.20.
| Document | Date |
|---|---|
| Annual report FY2026 DR. AGARWAL'S HEALTH CARE LIMITED – ANNUAL REPORT 2025-26 SUMMARY HEADLINE NUMBERS • Total Income: ₹2,125 Cr (20.9% y-o-y growth) • EBITDA: ₹614 Cr | 2026-08-28 |
| Q1 FY27 earnings call DR. AGARWAL'S HEALTHCARE LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Total Income: INR 620 crores, up 24% year-on-year • Revenue from Operations: I | 2026-08-07 |
| Investor presentation · Q1 FY27 DR. AGARWAL'S HEALTH CARE LIMITED – Q1'FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹614 Cr in Q1'FY27, up 26.0% YoY from ₹487 | 2026-08-04 |
| Quarterly results · Q1 FY27 DR. AGARWAL'S HEALTH CARE LIMITED – Q1 FY2027 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹614 Crores in Q1 FY2027, up 26.0% YoY (₹487 Cr in | 2026-08-04 |
| Q4 FY26 earnings call DR. AGARWAL'S HEALTHCARE LIMITED – Q4 FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Total income FY26: INR 2,125 crores, up 20.9% YoY • Revenue from oper | 2026-05-27 |
| Investor presentation · Q4 FY26 DR. AGARWAL'S HEALTH CARE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Total Income FY26: ₹2,125 Cr | YoY Growth: 20.9% • EBITDA FY26: ₹614 Cr (Ind | 2026-05-21 |
| Quarterly results · Q4 FY26 DR. AGARWAL'S HEALTH CARE LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • FY2026 Total Income: ₹2,125 Crores – growth of 20.9% YoY (FY2025: ₹1,757 Cro | 2026-05-21 |
| Q3 FY26 earnings call DR. AGARWAL'S HEALTH CARE LIMITED – Q3 & 9M FY26 SUMMARY HEADLINE NUMBERS • 9-Month Revenue (Apr-Dec 2025): Rs.1,516 crores, up 21.2% YoY • 9-Month | 2026-02-10 |
Readable in the app.
| Announcement | Date |
|---|---|
| Scheme of amalgamation petition hearing notice published Dr. Agarwal's Eye Hospital Limited has filed a petition for a court hearing regarding a proposed scheme of amalgamation (merger) with Dr. Agarwal's Health Care Limited. This is a legal notic | 2026-07-20 |
| Investment in Orbit Health Care ETH PLC through subsidiary Dr. Agarwal's Health Care Limited announced that its subsidiary company, Orbit Healthcare Services (Mauritius) Limited, has made an investment in Orbit Health Care ETH PLC. This is an update | 2026-05-26 |
| Receipt of observation letter for amalgamation scheme with no adverse observations Dr. Agarwal's Eye Hospital Limited has received an approval letter from stock exchanges (BSE and NSE) with no adverse observations regarding its proposed merger with Dr. Agarwal's Health Car | 2026-02-17 |
| Update on acquisition of another business or strategic stake Dr. Agarwal's Health Care Limited has informed the Exchange regarding 'Update on Acquisition'. | 2025-09-26 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Dr. Agarwal's Health Care Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.